ICD-10-CM Billable Code

C85.90

Non-Hodgkin lymphoma, unspecified, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Non-Hodgkin lymphoma (NHL) is a type of cancer that originates in the lymphatic system, which is a part of the immune system. The lymphatic system is made up of lymph nodes, vessels, and organs such as the spleen and thymus. When the specific site of the lymphoma cannot be identified or described, it is classified as 'unspecified' under the ICD-10 code C85.90. This form of NHL can affect people of all ages and often develops gradually, sometimes being discovered during investigations for other conditions. Understanding the nature of this disease can help in recognizing possible symptoms and the importance of diagnosis and treatment.

Causes & Symptoms

Clinical Causes: Genetic mutations that affect lymphocytes Compromised immune system due to conditions like HIV/AIDS or immunosuppressive therapies Exposure to certain chemicals such as pesticides and herbicides Older age, as risk increases with age Previous history of other cancers or certain infections, like Epstein-Barr virus or Helicobacter pylori

Key Symptoms: Swollen lymph nodes, often painless, in areas such as the neck, armpits, or groin Unexplained weight loss Persistent fever without an apparent cause Night sweats Fatigue or general feeling of being unwell Itching skin Abdominal pain or swelling, if the lymphoma involves abdominal organs Shortness of breath or cough if the chest area is affected

Diagnostic & Treatment

Diagnosis Path: Detecting non-Hodgkin lymphoma, unspecified involves a variety of tests and examinations. Typically, diagnosis begins with a physical exam to check for swollen lymph nodes and other signs. This is followed by imaging tests such as CT scans, PET scans, or MRI to determine the extent of the disease. A definitive diagnosis requires a biopsy, where a small sample of affected tissue is examined microscopically to identify cancer cells. Additional blood tests may be conducted to assess overall health and organ function. Sometimes, bone marrow biopsies are also performed to determine if the cancer has spread to the marrow.

Treatment Protocols: The management of non-Hodgkin lymphoma, unspecified depends on various factors including the lymphoma’s subtype, stage, and the patient's overall health. Common treatment options include chemotherapy, which uses drugs to kill cancer cells, and immunotherapy, which helps the immune system recognize and attack the cancer. Radiation therapy may be used to target specific areas affected by the lymphoma. In some cases, targeted therapy, which involves drugs that specifically attack cancer cells, or stem cell transplants can be recommended. Supportive care such as managing symptoms and preventing infections is also essential throughout treatment. The specific approach will be tailored by the healthcare team to optimize outcomes and quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C85.90 a billable ICD-10 code?
Yes, C85.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C85.90?
Clinical documentation must specify the nature of Non-Hodgkin lymphoma, unspecified, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference